1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REGENXBIO INC

Regenxbio Inc

XNAS: RGNX

Momentum Trap
Download real time

8.02 0.22 (2.82%)

65.34% Fall from 52W High

1.2M XNAS Volume

XNAS 19 Mar, 2025 11:28 AM (EDT)

Watchlist

Portfolio

Share
16S
9W
1O
2T
401.7

Market Cap

Below industry Median
-1.8

PE TTM

Negative PE TTM
-0.1

PEG TTM

PEG TTM is negative
1.3

Price to Book

Below industry Median
-0.1

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Regenxbio Inc is on 20 Mar 2025 for the purpose of Regenxbio Inc Annual Report for 2024 See details


Insider Trading disclosures for Regenxbio Inc

The latest disclosure was made by Curran Simpson in Regenxbio Inc where a trade of 98,912 Common Stock done was reported to US exchanges on Jan. 2, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Curran Simpson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 98,912 257,032 (0%) 0% 0 Common Stock
Curran Simpson Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.73 per share. 02 Jan 2025 11,917 158,120 (0%) 0% 7.7 92,118 Common Stock
Curran Simpson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 476,606 476,606 - - Stock Options (Right to buy)
Patrick J. Christmas Chief Legal Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.73 per share. 02 Jan 2025 11,395 160,810 (0%) 0% 7.7 88,083 Common Stock
Patrick J. Christmas Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 223,350 223,350 - - Stock Options (Right to buy)
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 59,347 231,800 (0%) 0% 0 Common Stock
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 95,721 95,721 - - Stock Options (Right to buy)
Olivier Danos Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.73 per share. 02 Jan 2025 12,630 172,453 (0%) 0% 7.7 97,630 Common Stock
Stephen Pakola Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.73 per share. 02 Jan 2025 13,891 151,687 (0%) 0% 7.7 107,377 Common Stock
Stephen Pakola Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 103,698 103,698 - - Stock Options (Right to buy)
Stephen Pakola Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 64,293 215,980 (0%) 0% 0 Common Stock
Mitchell Chan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 62,547 62,547 - - Stock Options (Right to buy)
Curran Simpson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 478,606 478,606 - - Stock Options (Right to buy)
Argeris N. Karabelas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 01 Oct 2024 10,000 21,286 (0%) 0% 3.8 37,600 Common Stock
Argeris N. Karabelas Director Sale of securities on an exchange or to another person at price $ 10.11 per share. 01 Oct 2024 10,000 11,286 (0%) 0% 10.1 101,052 Common Stock
Argeris N. Karabelas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2024 10,000 0 - - Stock Options (Right to Buy)
Mitchell Chan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2024 289,362 289,362 - - Stock Options (Right to buy)
Mitchell Chan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2024 58,869 58,869 (0%) 0% 0 Common Stock
Argeris N. Karabelas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Sep 2024 10,000 10,000 - - Stock Options (Right to Buy)
Argeris N. Karabelas Director Sale of securities on an exchange or to another person at price $ 12.34 per share. 03 Sep 2024 700 11,286 (0%) 0% 12.3 8,638 Common Stock
Argeris N. Karabelas Director Sale of securities on an exchange or to another person at price $ 11.50 per share. 03 Sep 2024 9,300 11,986 (0%) 0% 11.5 106,950 Common Stock
Argeris N. Karabelas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 03 Sep 2024 10,000 21,286 (0%) 0% 3.8 37,600 Common Stock
Kenneth T. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Aug 2024 36,316 0 - - Stock Options (Right to Buy)
Kenneth T. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 08 Aug 2024 36,316 444,351 (1%) 0% 0.9 30,869 Common Stock
Argeris N. Karabelas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 01 Aug 2024 10,000 21,286 (0%) 0% 3.8 37,600 Common Stock
Argeris N. Karabelas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2024 10,000 20,000 - - Stock Options (Right to Buy)
Argeris N. Karabelas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2024 100 1,400 - - Stock Options (Right to Buy)
Argeris N. Karabelas Director Sale of securities on an exchange or to another person at price $ 15.00 per share. 01 Aug 2024 100 11,286 (0%) 0% 15 1,500 Common Stock
Argeris N. Karabelas Director Sale of securities on an exchange or to another person at price $ 14.58 per share. 01 Aug 2024 400 11,386 (0%) 0% 14.6 5,834 Common Stock
Argeris N. Karabelas Director Sale of securities on an exchange or to another person at price $ 13.45 per share. 01 Aug 2024 9,600 11,786 (0%) 0% 13.5 129,120 Common Stock
Argeris N. Karabelas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.74 per share. 01 Aug 2024 100 21,386 (0%) 0% 12.7 1,274 Common Stock
Curran Simpson Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 15.00 per share. 01 Aug 2024 100 170,037 (0%) 0% 15 1,500 Common Stock
Patrick J. Christmas Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2024 56,446 172,205 (0%) 0% 0 Common Stock
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2024 58,867 185,083 (0%) 0% 0 Common Stock
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 9.94 per share. 01 Aug 2024 1,363 126,216 (0%) 0% 9.9 13,555 Common Stock
Stephen Pakola Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2024 58,386 165,578 (0%) 0% 0 Common Stock
Argeris N. Karabelas Director Sale of securities on an exchange or to another person at price $ 15.04 per share. 29 Jul 2024 11,000 11,286 (0%) 0% 15.0 165,495 Common Stock
Argeris N. Karabelas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.74 per share. 29 Jul 2024 11,000 22,286 (0%) 0% 12.7 140,140 Common Stock
Argeris N. Karabelas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jul 2024 11,000 1,500 - - Stock Options (Right to Buy)
Curran Simpson Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 15.04 per share. 29 Jul 2024 9,648 170,137 (0%) 0% 15.0 145,106 Common Stock
Kenneth T. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 24 Jul 2024 12,221 420,256 (1%) 0% 3.8 45,951 Common Stock
Kenneth T. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Jul 2024 15,369 51,354 - - Stock Options (Right to Buy)
Kenneth T. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Jul 2024 12,221 66,723 - - Stock Options (Right to Buy)
Kenneth T. Mills Director Sale of securities on an exchange or to another person at price $ 13.96 per share. 24 Jul 2024 15,369 408,035 (1%) 0% 14.0 214,501 Common Stock
Kenneth T. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 24 Jul 2024 15,369 423,404 (1%) 0% 3.8 57,787 Common Stock
Kenneth T. Mills Director Sale of securities on an exchange or to another person at price $ 13.78 per share. 24 Jul 2024 12,221 408,035 (1%) 0% 13.8 168,433 Common Stock
Kenneth T. Mills Director Sale of securities on an exchange or to another person at price $ 13.76 per share. 16 Jul 2024 200 408,035 (1%) 0% 13.8 2,752 Common Stock
Kenneth T. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jul 2024 2,210 78,944 - - Stock Options (Right to Buy)
Kenneth T. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jul 2024 200 81,154 - - Stock Options (Right to Buy)
Kenneth T. Mills Director Sale of securities on an exchange or to another person at price $ 13.77 per share. 16 Jul 2024 2,210 408,035 (1%) 0% 13.8 30,440 Common Stock
Kenneth T. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 16 Jul 2024 2,210 410,245 (1%) 0% 3.8 8,310 Common Stock
Kenneth T. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 16 Jul 2024 200 408,235 (1%) 0% 3.8 752 Common Stock
Argeris N. Karabelas Director Sale of securities on an exchange or to another person at price $ 11.27 per share. 01 Jul 2024 10,000 11,286 (0%) 0% 11.3 112,691 Common Stock
Argeris N. Karabelas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2024 10,000 30,000 - - Stock Options (Right to Buy)
Argeris N. Karabelas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 01 Jul 2024 10,000 21,286 (0%) 0% 3.8 37,600 Common Stock
Curran Simpson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2024 56,458 179,785 (0%) 0% 0 Common Stock
Curran Simpson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2024 272,189 272,189 - - Stock Options (Right to Buy)
Argeris N. Karabelas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 24,454 24,454 - - Stock Options (Right to Buy)
Argeris N. Karabelas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 4,790 11,286 (0%) 0% 0 Common Stock
David C. Stump Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 4,790 11,286 (0%) 0% 0 Common Stock
David C. Stump Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 24,454 24,454 - - Stock Options (Right to Buy)
George V. Migausky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 24,454 24,454 - - Stock Options (Right to Buy)
George V. Migausky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 4,790 11,286 (0%) 0% 0 Common Stock
Daniel Tasse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 4,790 11,286 (0%) 0% 0 Common Stock
Daniel Tasse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 24,454 24,454 - - Stock Options (Right to Buy)
Allan M. Fox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 4,790 11,286 (0%) 0% 0 Common Stock
Allan M. Fox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 24,454 24,454 - - Stock Options (Right to Buy)
Alexandra Glucksmann Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 24,454 24,454 - - Stock Options (Right to Buy)
Alexandra Glucksmann Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 4,790 11,286 (0%) 0% 0 Common Stock
Jennifer Zachary Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 4,790 14,296 (0%) 0% 0 Common Stock
Jennifer Zachary Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 24,454 24,454 - - Stock Options (Right to Buy)
Jean Bennett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 24,454 24,454 - - Stock Options (Right to Buy)
Jean Bennett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 4,790 11,286 (0%) 0% 0 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2024 15,000 81,354 - - Stock Options (Right to Buy)
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.81 per share. 14 May 2024 15,000 408,035 (1%) 0% 15.8 237,222 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 14 May 2024 15,000 423,035 (1%) 0% 3.8 56,400 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 15 Apr 2024 15,000 423,035 (1%) 0% 3.8 56,400 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 15,000 96,354 - - Stock Options (Right to Buy)
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 18.19 per share. 15 Apr 2024 15,000 408,035 (1%) 0% 18.2 272,871 Common Stock
Vasista Vittal Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Mar 2024 20,041 0 - - Employee Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 19 Mar 2024 20,041 246,534 (0%) 0% 3.8 75,354 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2024 15,000 111,354 - - Stock Options (Right to Buy)
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 21.86 per share. 14 Mar 2024 15,000 408,035 (1%) 0% 21.9 327,942 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 14 Mar 2024 15,000 423,035 (1%) 0% 3.8 56,400 Common Stock
Steve Pakola Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.25 per share. 05 Mar 2024 12,878 120,070 (0%) 0% 22.3 286,536 Common Stock
Steve Pakola Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Mar 2024 12,878 31,277 - - Stock Options (Right to Buy)
Steve Pakola Chief Medical Officer Sale of securities on an exchange or to another person at price $ 28.36 per share. 05 Mar 2024 12,878 107,192 (0%) 0% 28.4 365,220 Common Stock
Mills Kenneth T. Director, President and CEO Sale of securities on an exchange or to another person at price $ 16.47 per share. 14 Feb 2024 4,652 418,383 (1%) 0% 16.5 76,626 Common Stock
Kenneth Mills T. Director, President and CEO Sale of securities on an exchange or to another person at price $ 16.88 per share. 14 Feb 2024 10,348 408,035 (1%) 0% 16.9 174,723 Common Stock
Kenneth Mills T. Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 14 Feb 2024 15,000 423,035 (1%) 0% 3.8 56,400 Common Stock
Kenneth Mills T. Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 15,000 126,354 - - Stock Options (Right to Buy)
Kenneth Mills T. Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jan 2024 45,000 141,354 - - Stock Options (Right to Buy)
T. Kenneth Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.18 per share. 16 Jan 2024 45,000 408,035 (1%) 0% 15.2 682,992 Common Stock
Kenneth Mills T. Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 16 Jan 2024 45,000 453,035 (1%) 0% 3.8 169,200 Common Stock
Steve Pakola Chief Medical Officer Sale of securities on an exchange or to another person at price $ 17.39 per share. 02 Jan 2024 17,237 107,192 (0%) 0% 17.4 299,789 Common Stock
Olivier Danos Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.95 per share. 02 Jan 2024 8,410 86,391 (0%) 0% 18.0 150,960 Common Stock
Simpson Curran Chief Oper. & Tech. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 38,462 123,327 (0%) 0% 0 Common Stock
Simpson Curran Chief Oper. & Tech. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 61,050 61,050 - - Stock Options (Right to buy)
Christmas Patrick J. Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 54,945 54,945 - - Stock Options (Right to buy)
Pakola Steve Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 50,875 50,875 - - Stock Options (Right to buy)
Christmas Patrick J. Chief Legal Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.95 per share. 02 Jan 2024 7,893 81,144 (0%) 0% 17.9 141,679 Common Stock
Simpson Curran Chief Oper. & Tech. Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.95 per share. 02 Jan 2024 8,120 84,865 (0%) 0% 18.0 145,754 Common Stock
Vasista Vittal Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.95 per share. 02 Jan 2024 4,534 210,467 (0%) 0% 17.9 81,385 Common Stock
Danos Olivier Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 38,462 124,853 (0%) 0% 0 Common Stock
Danos Olivier Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 61,050 61,050 - - Stock Options (Right to buy)
Pakola Steve Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.95 per share. 02 Jan 2024 10,385 92,378 (0%) 0% 18.0 186,411 Common Stock
Mills T. Kenneth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 64,103 408,035 (1%) 0% 0 Common Stock
Vasista Vittal Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 16,026 226,493 (0%) 0% 0 Common Stock
Christmas J. Patrick Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 34,615 115,759 (0%) 0% 0 Common Stock
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 16.99 per share. 02 Jan 2024 1,123 94,801 (0%) 0% 17.0 19,081 Common Stock
Vittal Vasista Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 76,313 76,313 - - Stock Options (Right to buy)
Kenneth Mills T. Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.95 per share. 02 Jan 2024 11,357 343,932 (0%) 0% 17.9 203,858 Common Stock
Steve Pakola Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 32,051 124,429 (0%) 0% 0 Common Stock
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 20.99 per share. 02 Jan 2024 728 93,678 (0%) 0% 21.0 15,284 Common Stock
Mills Kenneth T. Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 305,250 305,250 - - Stock Options (Right to buy)
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 1,500 36,316 - - Stock Options (Right to Buy)
Mills Kenneth T. Director, President and CEO Sale of securities on an exchange or to another person at price $ 19.68 per share. 19 Dec 2023 45,000 355,289 (0%) 0% 19.7 885,825 Common Stock
T. Kenneth Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 19 Dec 2023 1,500 400,289 (1%) 0% 0.9 1,275 Common Stock
T. Mills Kenneth Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 43,500 186,354 - - Stock Options (Right to Buy)
T. Kenneth Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 19 Dec 2023 43,500 398,789 (1%) 0% 3.8 163,560 Common Stock
Argeris N. Karabelas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 3,486 6,496 (0%) 0% 0 Common Stock
Argeris N. Karabelas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 17,892 17,892 - - Stock Options (Right to Buy)
David C. Stump Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 17,892 17,892 - - Stock Options (Right to Buy)
David C. Stump Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 3,486 6,496 (0%) 0% 0 Common Stock
George V. Migausky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 17,892 17,892 - - Stock Options (Right to Buy)
George V. Migausky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 3,486 6,496 (0%) 0% 0 Common Stock
Daniel Tasse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 17,892 17,892 - - Stock Options (Right to Buy)
Daniel Tasse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 3,486 6,496 (0%) 0% 0 Common Stock
Allan M. Fox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 17,892 17,892 - - Stock Options (Right to Buy)
Allan M. Fox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 3,486 6,496 (0%) 0% 0 Common Stock
Alexandra Glucksmann Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 3,486 6,496 (0%) 0% 0 Common Stock
Alexandra Glucksmann Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 17,892 17,892 - - Stock Options (Right to Buy)
Jennifer Zachary Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 3,486 9,506 (0%) 0% 0 Common Stock
Jennifer Zachary Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 17,892 17,892 - - Stock Options (Right to Buy)
Jean Bennett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 17,892 17,892 - - Stock Options (Right to Buy)
Jean Bennett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2023 3,486 6,496 (0%) 0% 0 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 May 2023 35,000 0 - - Employee Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 31 May 2023 35,000 215,001 (0%) 0% 0.9 29,750 Common Stock
Curran Simpson Chief Oper. & Tech. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 52,986 52,986 - - Stock Options (Right to buy)
Curran Simpson Chief Oper. & Tech. Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.68 per share. 03 Jan 2023 2,076 25,040 (0%) 0% 22.7 47,084 Common Stock
Curran Simpson Chief Oper. & Tech. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 67,945 92,985 (0%) 0% 0 Common Stock
Patrick J. Christmas Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 67,940 89,037 (0%) 0% 0 Common Stock
Patrick J. Christmas Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 56,519 56,519 - - Stock Options (Right to buy)
Patrick J. Christmas Chief Legal Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.68 per share. 03 Jan 2023 1,843 21,097 (0%) 0% 22.7 41,799 Common Stock
Kenneth T. Mills Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.68 per share. 03 Jan 2023 9,308 300,536 (0%) 0% 22.7 211,105 Common Stock
Kenneth T. Mills Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 264,932 264,932 - - Stock Options (Right to buy)
Kenneth T. Mills Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 54,753 355,289 (0%) 0% 0 Common Stock
Vittal Vasista Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 46,174 180,001 (0%) 0% 0 Common Stock
Vittal Vasista Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 66,233 66,233 - - Stock Options (Right to buy)
Vittal Vasista Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.68 per share. 03 Jan 2023 1,333 133,827 (0%) 0% 22.7 30,232 Common Stock
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 52,986 52,986 - - Stock Options (Right to buy)
Olivier Danos Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.68 per share. 03 Jan 2023 2,058 27,020 (0%) 0% 22.7 46,675 Common Stock
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 65,930 92,950 (0%) 0% 0 Common Stock
Steve Pakola Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.68 per share. 03 Jan 2023 1,837 15,313 (0%) 0% 22.7 41,663 Common Stock
Steve Pakola Chief Medical Officer Sale of securities on an exchange or to another person at price $ 22.17 per share. 03 Jan 2023 3,138 12,175 (0%) 0% 22.2 69,559 Common Stock
Steve Pakola Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 44,155 44,155 - - Stock Options (Right to buy)
Steve Pakola Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 90,588 102,763 (0%) 0% 0 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 30.24 per share. 30 Aug 2022 2,400 135,160 (0%) 0% 30.2 72,573 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 35.19 per share. 04 Aug 2022 17,280 137,560 (0%) 0% 35.2 608,035 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 35.00 per share. 04 Aug 2022 400 154,840 (0%) 0% 35 14,000 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 31.26 per share. 01 Aug 2022 2,400 155,240 (0%) 0% 31.3 75,012 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 30.01 per share. 13 Jul 2022 4,332 158,108 (0%) 0% 30.0 129,988 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 30.00 per share. 13 Jul 2022 468 157,640 (0%) 0% 30 14,040 Common Stock
Argeris N. Karabelas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 3,010 3,010 (0%) 0% 0 Common Stock
Argeris N. Karabelas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 15,324 15,324 - - Stock Option (Right to Buy)
David C. Stump Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 15,324 15,324 - - Stock Option (Right to Buy)
David C. Stump Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 3,010 3,010 (0%) 0% 0 Common Stock
George V. Migausky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 15,324 15,324 - - Stock Option (Right to Buy)
George V. Migausky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 3,010 3,010 (0%) 0% 0 Common Stock
Daniel Tasse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 15,324 15,324 - - Stock Option (Right to Buy)
Daniel Tasse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 3,010 3,010 (0%) 0% 0 Common Stock
Allan M. Fox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 15,324 15,324 - - Stock Option (Right to Buy)
Allan M. Fox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 3,010 3,010 (0%) 0% 0 Common Stock
Alexandra Glucksmann Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 3,010 3,010 (0%) 0% 0 Common Stock
Alexandra Glucksmann Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 15,324 15,324 - - Stock Option (Right to Buy)
Jennifer Zachary Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 6,020 6,020 (0%) 0% 0 Common Stock
Jennifer Zachary Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 29,739 29,739 - - Stock Option (Right to Buy)
Jean Bennett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 3,010 3,010 (0%) 0% 0 Common Stock
Jean Bennett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 15,324 15,324 - - Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 20 Jan 2022 29,900 162,440 (0%) 0% 0.9 25,415 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2022 29,900 35,000 - - Employee Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 8,900 132,540 (0%) 0% 0 Common Stock
Vittal Vasista Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 42,500 42,500 - - Stock Option (Right to Buy)
Curran Simpson Chief Oper. & Tech. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 10,700 27,116 (0%) 0% 0 Common Stock
Curran Simpson Chief Oper. & Tech. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 51,100 51,100 - - Stock Option (Right to Buy)
Curran Simpson Chief Oper. & Tech. Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.70 per share. 01 Jan 2022 1,332 16,416 (0%) 0% 32.7 43,556 Common Stock
Patrick J. Christmas Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 7,900 22,940 (0%) 0% 0 Common Stock
Patrick J. Christmas Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 37,400 37,400 - - Stock Option (Right to Buy)
Patrick J. Christmas Chief Legal Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.70 per share. 01 Jan 2022 1,332 15,040 (0%) 0% 32.7 43,556 Common Stock
Kenneth T. Mills Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.70 per share. 01 Jan 2022 3,636 274,048 (0%) 0% 32.7 118,897 Common Stock
Kenneth T. Mills Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 35,796 309,844 (0%) 0% 0 Common Stock
Kenneth T. Mills Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 170,188 170,188 - - Stock Option (Right to Buy)
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 10,700 29,078 (0%) 0% 0 Common Stock
Olivier Danos Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.70 per share. 01 Jan 2022 1,221 18,378 (0%) 0% 32.7 39,927 Common Stock
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 28.00 per share. 01 Jan 2022 1 19,599 (0%) 0% 28 28 Common Stock
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 33.02 per share. 01 Jan 2022 555 19,598 (0%) 0% 33.0 18,327 Common Stock
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 51,100 51,100 - - Stock Option (Right to Buy)
Steve Pakola Chief Medical Officer Sale of securities on an exchange or to another person at price $ 33.75 per share. 01 Jan 2022 1,598 8,250 (0%) 0% 33.8 53,933 Common Stock
Steve Pakola Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 8,900 17,150 (0%) 0% 0 Common Stock
Steve Pakola Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 42,500 42,500 - - Stock Option (Right to Buy)
Steve Pakola Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.70 per share. 01 Jan 2022 1,152 9,848 (0%) 0% 32.7 37,670 Common Stock
Allan M. Fox Director Sale of securities on an exchange or to another person at price $ 34.40 per share. 22 Dec 2021 61,638 1,581,212 (4%) 0% 34.4 2,120,575 Common Stock
Allan M. Fox Director Sale of securities on an exchange or to another person at price $ 35.85 per share. 22 Dec 2021 6,323 1,529,981 (4%) 0% 35.8 226,664 Common Stock
Allan M. Fox Director Sale of securities on an exchange or to another person at price $ 34.92 per share. 22 Dec 2021 44,908 1,536,304 (4%) 0% 34.9 1,568,120 Common Stock
Kenneth T. Mills Director, President and CEO Gift of securities by or to the insider at price $ 0.00 per share. 02 Dec 2021 3,300 277,684 (0%) 0% 0 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 40.00 per share. 08 Nov 2021 1,500 280,984 (0%) 0% 40 60,000 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Nov 2021 1,500 229,854 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 08 Nov 2021 1,500 282,484 (0%) 0% 3.8 5,640 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 42.19 per share. 27 Sep 2021 1,500 280,984 (0%) 0% 42.2 63,285 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Sep 2021 1,500 231,354 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 27 Sep 2021 1,500 282,484 (0%) 0% 3.8 5,640 Common Stock
Allan M. Fox Director Sale of securities on an exchange or to another person at price $ 45.04 per share. 17 Sep 2021 48,233 1,364,309 (3%) 0% 45.0 2,172,323 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2021 33,146 232,854 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2021 1,854 37,816 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2021 3,000 266,000 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 45.11 per share. 13 Sep 2021 35,000 280,984 (0%) 0% 45.1 1,578,850 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 13 Sep 2021 1,854 315,984 (0%) 0% 0.9 1,576 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 13 Sep 2021 33,146 314,130 (0%) 0% 3.8 124,629 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 40.02 per share. 13 Sep 2021 3,000 280,984 (0%) 0% 40.0 120,060 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 13 Sep 2021 3,000 283,984 (0%) 0% 3.8 11,280 Common Stock
George V. Migausky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Sep 2021 20,000 20,000 - - Stock Option (Right to Buy)
Jean Bennett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Sep 2021 20,000 20,000 - - Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jul 2021 10,000 64,900 - - Employee Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 27 Jul 2021 10,000 123,640 (0%) 0% 0.9 8,500 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 24 Jun 2021 1,500 282,484 (0%) 0% 3.8 5,640 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 40.02 per share. 24 Jun 2021 4,500 280,984 (0%) 0% 40.0 180,090 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. 24 Jun 2021 4,500 285,484 (0%) 0% 3.8 16,920 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Jun 2021 1,500 269,000 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Jun 2021 4,500 270,500 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 40.25 per share. 24 Jun 2021 1,500 280,984 (0%) 0% 40.3 60,375 Common Stock
Argeris N. Karabelas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
Daniel J. Abdun-Nabi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
David C. Stump Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
Luke M. Beshar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
Daniel Tasse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
Allan M. Fox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
Alexandra Glucksmann Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 40.77 per share. 25 Feb 2021 1,500 280,984 (0%) 0% 40.8 61,155 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2021 1,500 39,670 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 25 Feb 2021 1,500 282,484 (0%) 0% 0.9 1,275 Common Stock
Patrick J. Christmas Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Feb 2021 4,701 6,430 - - Employee Stock Option (Right to Buy)
Patrick J. Christmas Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.10 per share. 12 Feb 2021 4,701 21,073 (0%) 0% 12.1 56,882 Common Stock
Patrick J. Christmas Chief Legal Officer Sale of securities on an exchange or to another person at price $ 49.08 per share. 12 Feb 2021 4,701 16,372 (0%) 0% 49.1 230,725 Common Stock
Patrick J. Christmas Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2021 1,300 11,131 - - Employee Stock Option (Right to Buy)
Patrick J. Christmas Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.10 per share. 08 Feb 2021 1,300 17,672 (0%) 0% 12.1 15,730 Common Stock
Patrick J. Christmas Chief Legal Officer Sale of securities on an exchange or to another person at price $ 49.11 per share. 08 Feb 2021 1,300 16,372 (0%) 0% 49.1 63,843 Common Stock
Patrick J. Christmas Chief Legal Officer Sale of securities on an exchange or to another person at price $ 44.77 per share. 02 Feb 2021 9,500 16,872 (0%) 0% 44.8 425,315 Common Stock
Patrick J. Christmas Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.10 per share. 02 Feb 2021 10,000 26,372 (0%) 0% 12.1 121,000 Common Stock
Patrick J. Christmas Chief Legal Officer Sale of securities on an exchange or to another person at price $ 45.13 per share. 02 Feb 2021 500 16,372 (0%) 0% 45.1 22,565 Common Stock
Patrick J. Christmas Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Feb 2021 10,000 12,431 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 44.99 per share. 25 Jan 2021 5,211 280,984 (0%) 0% 45.0 234,443 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 44.05 per share. 25 Jan 2021 974 286,195 (0%) 0% 44.1 42,905 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 42.64 per share. 25 Jan 2021 315 287,169 (0%) 0% 42.6 13,432 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 25 Jan 2021 6,500 287,484 (0%) 0% 0.9 5,525 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2021 6,500 41,170 - - Employee Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 50.04 per share. 15 Jan 2021 252 113,640 (0%) 0% 50.0 12,610 Common Stock
Curran Simpson Chief Oper. & Tech. Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.50 per share. 12 Jan 2021 1,240 18,988 (0%) 0% 19.5 24,180 Common Stock
Curran Simpson Chief Oper. & Tech. Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.50 per share. 12 Jan 2021 1,700 19,448 (0%) 0% 19.5 33,150 Common Stock
Curran Simpson Chief Oper. & Tech. Officer Sale of securities on an exchange or to another person at price $ 50.03 per share. 12 Jan 2021 1,700 17,748 (0%) 0% 50.0 85,051 Common Stock
Curran Simpson Chief Oper. & Tech. Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jan 2021 10,372 17,128 - - Stock Option (Right to Buy)
Curran Simpson Chief Oper. & Tech. Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jan 2021 1,240 0 - - Stock Option (Right to Buy)
Curran Simpson Chief Oper. & Tech. Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jan 2021 1,700 1,240 - - Stock Option (Right to Buy)
Curran Simpson Chief Oper. & Tech. Officer Sale of securities on an exchange or to another person at price $ 50.01 per share. 12 Jan 2021 11,612 17,748 (0%) 0% 50.0 580,716 Common Stock
Curran Simpson Chief Oper. & Tech. Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.80 per share. 12 Jan 2021 10,372 29,360 (0%) 0% 35.8 371,318 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 50.03 per share. 12 Jan 2021 11,093 113,892 (0%) 0% 50.0 554,983 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 50.01 per share. 12 Jan 2021 4,200 124,985 (0%) 0% 50.0 210,042 Common Stock
Patrick J. Christmas Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2021 10,000 29,931 - - Employee Stock Option (Right to Buy)
Patrick J. Christmas Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2021 1,378 641 - - Stock Option (Right to Buy)
Patrick J. Christmas Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2021 2,622 2,019 - - Stock Option (Right to Buy)
Patrick J. Christmas Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2021 7,500 22,431 - - Employee Stock Option (Right to Buy)
Patrick J. Christmas Chief Legal Officer Sale of securities on an exchange or to another person at price $ 49.15 per share. 08 Jan 2021 1,378 16,372 (0%) 0% 49.2 67,729 Common Stock
Patrick J. Christmas Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.50 per share. 08 Jan 2021 1,378 17,750 (0%) 0% 19.5 26,871 Common Stock
Patrick J. Christmas Chief Legal Officer Sale of securities on an exchange or to another person at price $ 49.08 per share. 08 Jan 2021 10,122 16,372 (0%) 0% 49.1 496,788 Common Stock
Patrick J. Christmas Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.50 per share. 08 Jan 2021 2,622 26,494 (0%) 0% 19.5 51,129 Common Stock
Patrick J. Christmas Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.10 per share. 08 Jan 2021 7,500 23,872 (0%) 0% 12.1 90,750 Common Stock
Patrick J. Christmas Chief Legal Officer Sale of securities on an exchange or to another person at price $ 48.13 per share. 08 Jan 2021 1,320 16,372 (0%) 0% 48.1 63,532 Common Stock
Patrick J. Christmas Chief Legal Officer Sale of securities on an exchange or to another person at price $ 47.42 per share. 08 Jan 2021 4,062 17,692 (0%) 0% 47.4 192,620 Common Stock
Patrick J. Christmas Chief Legal Officer Sale of securities on an exchange or to another person at price $ 46.43 per share. 08 Jan 2021 4,618 21,754 (0%) 0% 46.4 214,414 Common Stock
Patrick J. Christmas Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.10 per share. 08 Jan 2021 10,000 26,372 (0%) 0% 12.1 121,000 Common Stock
Curran Simpson Chief Oper. & Tech. Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jan 2021 5,185 2,940 - - Stock Option (Right to Buy)
Curran Simpson Chief Oper. & Tech. Officer Sale of securities on an exchange or to another person at price $ 50.01 per share. 07 Jan 2021 5,185 17,748 (0%) 0% 50.0 259,302 Common Stock
Curran Simpson Chief Oper. & Tech. Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.50 per share. 07 Jan 2021 5,185 22,933 (0%) 0% 19.5 101,108 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 07 Jan 2021 1,500 283,484 (0%) 0% 0.9 1,275 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jan 2021 1,500 47,670 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 50.01 per share. 07 Jan 2021 1,500 281,984 (0%) 0% 50.0 75,015 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 46.45 per share. 07 Jan 2021 2,460 131,966 (0%) 0% 46.5 114,267 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 48.15 per share. 07 Jan 2021 573 129,185 (0%) 0% 48.2 27,590 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 47.49 per share. 07 Jan 2021 2,208 129,758 (0%) 0% 47.5 104,858 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 50.00 per share. 07 Jan 2021 10,998 134,426 (0%) 0% 50 549,900 Common Stock
Curran Simpson Chief Oper. & Tech. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 62,300 62,300 - - Stock Option (Right to Buy)
Curran Simpson Chief Oper. & Tech. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 13,800 17,748 (0%) 0% 0 Common Stock
Patrick J. Christmas Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 62,500 62,500 - - Stock Option (Right to Buy)
Patrick J. Christmas Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 13,800 16,372 (0%) 0% 0 Common Stock
Kenneth T. Mills Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 40,984 281,984 (0%) 0% 0 Common Stock
Kenneth T. Mills Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 185,167 185,167 - - Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 56,200 56,200 - - Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 12,400 145,424 (0%) 0% 0 Common Stock
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 31.31 per share. 04 Jan 2021 641 7,443 (0%) 0% 31.3 20,067 Common Stock
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 34.82 per share. 04 Jan 2021 302 6,802 (0%) 0% 34.8 10,517 Common Stock
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 52,500 52,500 - - Stock Option (Right to Buy)
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 11,600 19,043 (0%) 0% 0 Common Stock
Steve Pakola Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 11,000 11,000 (0%) 0% 0 Common Stock
Steve Pakola Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 49,700 49,700 - - Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Dec 2020 6,500 49,170 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 28 Dec 2020 6,500 247,500 (0%) 0% 0.9 5,525 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 48.47 per share. 28 Dec 2020 4,647 242,853 (0%) 0% 48.5 225,240 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 49.16 per share. 28 Dec 2020 1,853 241,000 (0%) 0% 49.2 91,093 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 50.00 per share. 23 Dec 2020 4,500 241,000 (0%) 0% 50 225,000 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2020 4,500 55,670 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 23 Dec 2020 4,500 245,500 (0%) 0% 0.9 3,825 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 50.00 per share. 23 Dec 2020 3,376 133,024 (0%) 0% 50 168,800 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 50.01 per share. 23 Dec 2020 21,124 136,400 (0%) 0% 50.0 1,056,411 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 45.00 per share. 16 Dec 2020 15,000 241,000 (0%) 0% 45 675,000 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2020 15,000 60,170 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 16 Dec 2020 15,000 256,000 (0%) 0% 0.9 12,750 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 40.00 per share. 10 Dec 2020 4,500 241,000 (0%) 0% 40 180,000 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2020 4,500 75,170 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 10 Dec 2020 4,500 245,500 (0%) 0% 0.9 3,825 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 40.17 per share. 10 Dec 2020 14,916 157,524 (0%) 0% 40.2 599,176 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 40.06 per share. 10 Dec 2020 22,584 172,440 (0%) 0% 40.1 904,715 Common Stock
Allan M. Fox Director Gift of securities by or to the insider at price $ 0.00 per share. 27 Jul 2020 90,000 315,000 (0%) 0% 0 Common Stock
Allan M. Fox Director Gift of securities by or to the insider at price $ 0.00 per share. 27 Jul 2020 90,000 1,324,110 (3%) 0% 0 Common Stock
Allan M. Fox Director Gift of securities by or to the insider at price $ 0.00 per share. 27 Jul 2020 225,000 225,000 (0%) 0% 0 Common Stock
Allan M. Fox Director Gift of securities by or to the insider at price $ 0.00 per share. 27 Jul 2020 225,000 1,414,110 (3%) 0% 0 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2020 3,259 14,115 - - Employee Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 40.10 per share. 15 Jul 2020 14,950 195,024 (0%) 0% 40.1 599,495 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.09 per share. 15 Jul 2020 3,259 209,974 (0%) 0% 13.1 42,660 Common Stock
Argeris N. Karabelas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2020 10,000 10,000 - - Stock Option (Right to Buy)
Daniel J. Abdun-Nabi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2020 10,000 10,000 - - Stock Option (Right to Buy)
David C. Stump Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2020 10,000 10,000 - - Stock Option (Right to Buy)
Donald J. Hayden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2020 10,000 10,000 - - Stock Option (Right to Buy)
Luke M. Beshar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2020 10,000 10,000 - - Stock Option (Right to Buy)
Daniel Tasse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2020 10,000 10,000 - - Stock Option (Right to Buy)
Allan M. Fox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2020 10,000 10,000 - - Stock Option (Right to Buy)
Alexandra Glucksmann Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2020 10,000 10,000 - - Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 40.18 per share. 08 May 2020 7,000 206,715 (0%) 0% 40.2 281,260 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 May 2020 500 17,374 - - Employee Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 May 2020 2,500 17,874 - - Employee Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 40.00 per share. 08 May 2020 500 206,715 (0%) 0% 40 20,000 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.09 per share. 08 May 2020 500 207,215 (0%) 0% 13.1 6,545 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.09 per share. 08 May 2020 2,500 213,715 (0%) 0% 13.1 32,725 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Apr 2020 3,000 23,374 - - Employee Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Apr 2020 3,000 20,374 - - Employee Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 40.11 per share. 23 Apr 2020 12,000 211,215 (0%) 0% 40.1 481,320 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.09 per share. 23 Apr 2020 3,000 223,215 (0%) 0% 13.1 39,270 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 40.00 per share. 23 Apr 2020 3,000 220,215 (0%) 0% 40 120,000 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.09 per share. 23 Apr 2020 3,000 223,215 (0%) 0% 13.1 39,270 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2020 10,000 74,900 - - Employee Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 31 Mar 2020 10,000 220,215 (0%) 0% 0.9 8,500 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2020 14,928 6,633 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.50 per share. 10 Feb 2020 4,253 26,901 (0%) 0% 19.5 82,934 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.00 per share. 10 Feb 2020 14,928 41,829 (0%) 0% 22 328,416 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.80 per share. 10 Feb 2020 12,479 54,308 (0%) 0% 35.8 446,748 Common Stock
Curran Simpson SVP, Product Development & CTO Sale of securities on an exchange or to another person at price $ 50.22 per share. 10 Feb 2020 44,429 9,879 (0%) 0% 50.2 2,231,224 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.00 per share. 10 Feb 2020 6,633 16,512 (0%) 0% 22 145,926 Common Stock
Curran Simpson SVP, Product Development & CTO Sale of securities on an exchange or to another person at price $ 50.13 per share. 10 Feb 2020 8,872 7,640 (0%) 0% 50.1 444,753 Common Stock
Curran Simpson SVP, Product Development & CTO Sale of securities on an exchange or to another person at price $ 51.37 per share. 10 Feb 2020 3,692 3,948 (0%) 0% 51.4 189,658 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2020 12,479 27,500 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2020 4,253 8,125 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2020 6,633 0 - - Stock Option (Right to Buy)
Donald J. Hayden Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2020 24,800 129,100 - - Stock Option (Right to Buy)
Donald J. Hayden Director Sale of securities on an exchange or to another person at price $ 50.11 per share. 10 Feb 2020 24,800 0 (0%) 0% 50.1 1,242,728 Common Stock
Donald J. Hayden Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 10 Feb 2020 24,800 24,800 (0%) 0% 0.9 21,080 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 50.12 per share. 10 Feb 2020 14,129 210,215 (0%) 0% 50.1 708,145 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2020 3,000 26,374 - - Employee Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 49.05 per share. 10 Feb 2020 677 224,344 (0%) 0% 49.1 33,207 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.09 per share. 10 Feb 2020 3,000 225,021 (0%) 0% 13.1 39,270 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.00 per share. 05 Feb 2020 958 27,814 (0%) 0% 22 21,076 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.09 per share. 05 Feb 2020 2,708 25,856 (0%) 0% 13.1 35,448 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.50 per share. 05 Feb 2020 1,000 26,856 (0%) 0% 19.5 19,500 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Feb 2020 2,708 0 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Feb 2020 1,000 12,378 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Feb 2020 958 21,561 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Feb 2020 471 39,979 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Sale of securities on an exchange or to another person at price $ 50.00 per share. 05 Feb 2020 5,637 22,648 (0%) 0% 50 281,850 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.80 per share. 05 Feb 2020 471 28,285 (0%) 0% 35.8 16,862 Common Stock
Donald J. Hayden Director Sale of securities on an exchange or to another person at price $ 50.00 per share. 05 Feb 2020 2,000 0 (0%) 0% 50 100,000 Common Stock
Donald J. Hayden Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 05 Feb 2020 2,000 2,000 (0%) 0% 0.9 1,700 Common Stock
Donald J. Hayden Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Feb 2020 2,000 153,900 - - Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 50.00 per share. 05 Feb 2020 300 222,021 (0%) 0% 50 15,000 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.50 per share. 17 Jan 2020 1,622 25,570 (0%) 0% 19.5 31,629 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Jan 2020 1,622 13,378 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Jan 2020 2,700 22,519 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Jan 2020 800 40,450 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Sale of securities on an exchange or to another person at price $ 50.00 per share. 17 Jan 2020 5,922 23,148 (0%) 0% 50 296,100 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.80 per share. 17 Jan 2020 800 29,070 (0%) 0% 35.8 28,640 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.00 per share. 17 Jan 2020 2,700 28,270 (0%) 0% 22 59,400 Common Stock
Donald J. Hayden Director Sale of securities on an exchange or to another person at price $ 50.01 per share. 17 Jan 2020 3,200 0 (0%) 0% 50.0 160,032 Common Stock
Donald J. Hayden Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Jan 2020 3,200 155,900 - - Stock Option (Right to Buy)
Donald J. Hayden Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 17 Jan 2020 3,200 3,200 (0%) 0% 0.9 2,720 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 50.00 per share. 17 Jan 2020 2,394 222,321 (0%) 0% 50 119,700 Common Stock
Donald J. Hayden Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 14 Jan 2020 30,000 30,000 (0%) 0% 0.9 25,500 Common Stock
Donald J. Hayden Director Sale of securities on an exchange or to another person at price $ 45.60 per share. 14 Jan 2020 30,000 0 (0%) 0% 45.6 1,368,000 Common Stock
Donald J. Hayden Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jan 2020 30,000 159,100 - - Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 41.40 per share. 08 Jan 2020 2,400 229,815 (0%) 0% 41.4 99,360 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2020 3,000 29,374 - - Employee Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 41.92 per share. 08 Jan 2020 5,100 224,715 (0%) 0% 41.9 213,792 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.09 per share. 08 Jan 2020 3,000 232,215 (0%) 0% 13.1 39,270 Common Stock
Curran Simpson SVP, Product Development & CTO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 46,000 46,000 - - Stock Option (Right to Buy)
Patrick J. Christmas SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 50,000 50,000 - - Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 270,000 270,000 - - Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 50,000 50,000 - - Stock Option (Right to Buy)
Olivier Danos Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 48,000 48,000 - - Stock Option (Right to Buy)
Steve Pakola Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 42,600 42,600 - - Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2019 1,000 240,000 (0%) 0% 0 Common Stock
Curran Simpson SVP, Product Development & CTO Sale of securities on an exchange or to another person at price $ 43.40 per share. 09 Dec 2019 9,399 30,101 (0%) 0% 43.4 407,917 Common Stock
Curran Simpson SVP, Product Development & CTO Sale of securities on an exchange or to another person at price $ 44.26 per share. 09 Dec 2019 6,153 23,948 (0%) 0% 44.3 272,332 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Sep 2019 5,000 79,670 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 19 Sep 2019 5,000 251,000 (0%) 0% 0.9 4,250 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 39.91 per share. 19 Sep 2019 7,773 241,000 (0%) 0% 39.9 310,220 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 39.19 per share. 19 Sep 2019 2,227 248,773 (0%) 0% 39.2 87,276 Common Stock
Patrick J. Christmas SVP, General Counsel Sale of securities on an exchange or to another person at price $ 42.00 per share. 12 Sep 2019 5,486 2,572 (0%) 0% 42 230,412 Common Stock
Patrick J. Christmas SVP, General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2019 5,000 39,931 - - Employee Stock Option (Right to Buy)
Patrick J. Christmas SVP, General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.10 per share. 12 Sep 2019 5,000 8,058 (0%) 0% 12.1 60,500 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 37.54 per share. 19 Aug 2019 14,624 246,376 (0%) 0% 37.5 548,985 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Aug 2019 15,000 84,670 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 37.92 per share. 19 Aug 2019 376 246,000 (0%) 0% 37.9 14,258 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 19 Aug 2019 15,000 261,000 (0%) 0% 0.9 12,750 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 49.40 per share. 19 Jul 2019 12,700 248,300 (0%) 0% 49.4 627,380 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jul 2019 15,000 99,670 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 49.97 per share. 19 Jul 2019 2,300 246,000 (0%) 0% 50.0 114,931 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 19 Jul 2019 15,000 261,000 (0%) 0% 0.9 12,750 Common Stock
Patrick J. Christmas SVP, General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2019 4,900 4,641 - - Stock Option (Right to Buy)
Patrick J. Christmas SVP, General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2019 100 9,541 - - Stock Option (Right to Buy)
Patrick J. Christmas SVP, General Counsel Sale of securities on an exchange or to another person at price $ 50.03 per share. 30 Jun 2019 4,900 3,058 (0%) 0% 50.0 245,147 Common Stock
Patrick J. Christmas SVP, General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.50 per share. 30 Jun 2019 4,900 7,958 (0%) 0% 19.5 95,550 Common Stock
Patrick J. Christmas SVP, General Counsel Sale of securities on an exchange or to another person at price $ 50.00 per share. 30 Jun 2019 100 3,058 (0%) 0% 50 5,000 Common Stock
Patrick J. Christmas SVP, General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.50 per share. 30 Jun 2019 100 3,158 (0%) 0% 19.5 1,950 Common Stock
Patrick J. Christmas SVP, General Counsel Grant, award, or other acquisition of securities at price $ 36.83 per share. 30 Jun 2019 52 3,058 (0%) 0% 36.8 1,915 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jun 2019 15,000 114,670 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 53.25 per share. 19 Jun 2019 4,120 246,000 (0%) 0% 53.3 219,390 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 52.27 per share. 19 Jun 2019 10,880 250,120 (0%) 0% 52.3 568,698 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 19 Jun 2019 15,000 261,000 (0%) 0% 0.9 12,750 Common Stock
Patrick J. Christmas SVP, General Counsel Sale of securities on an exchange or to another person at price $ 52.74 per share. 18 Jun 2019 2,966 5,040 (0%) 0% 52.7 156,427 Common Stock
Patrick J. Christmas SVP, General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.10 per share. 18 Jun 2019 5,000 8,006 (0%) 0% 12.1 60,500 Common Stock
Patrick J. Christmas SVP, General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jun 2019 5,000 44,931 - - Employee Stock Option (Right to Buy)
Patrick J. Christmas SVP, General Counsel Sale of securities on an exchange or to another person at price $ 54.75 per share. 18 Jun 2019 100 3,006 (0%) 0% 54.8 5,475 Common Stock
Patrick J. Christmas SVP, General Counsel Sale of securities on an exchange or to another person at price $ 53.29 per share. 18 Jun 2019 1,934 3,106 (0%) 0% 53.3 103,063 Common Stock
Argeris N. Karabelas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2019 10,000 10,000 - - Stock Option (Right to Buy)
Daniel J. Abdun-Nabi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2019 10,000 10,000 - - Stock Option (Right to Buy)
David C. Stump Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2019 10,000 10,000 - - Stock Option (Right to Buy)
Donald J. Hayden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2019 10,000 10,000 - - Stock Option (Right to Buy)
Luke M. Beshar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2019 10,000 10,000 - - Stock Option (Right to Buy)
Daniel Tasse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2019 10,000 10,000 - - Stock Option (Right to Buy)
Allan M. Fox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2019 10,000 10,000 - - Stock Option (Right to Buy)
Alexandra Glucksmann Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2019 10,000 10,000 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Sale of securities on an exchange or to another person at price $ 50.00 per share. 28 May 2019 18,000 39,500 (0%) 0% 50 900,000 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 May 2019 18,000 25,219 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.00 per share. 28 May 2019 18,000 57,500 (0%) 0% 22 396,000 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 43.32 per share. 20 May 2019 10,559 246,300 (0%) 0% 43.3 457,416 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 20 May 2019 15,000 261,000 (0%) 0% 0.9 12,750 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 May 2019 15,000 129,670 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 43.99 per share. 20 May 2019 300 246,000 (0%) 0% 44.0 13,197 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 42.08 per share. 20 May 2019 4,141 256,859 (0%) 0% 42.1 174,253 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 52.33 per share. 22 Apr 2019 1,300 246,100 (0%) 0% 52.3 68,029 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 22 Apr 2019 15,000 261,000 (0%) 0% 0.9 12,750 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 49.29 per share. 22 Apr 2019 3,401 257,599 (0%) 0% 49.3 167,635 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 50.31 per share. 22 Apr 2019 6,929 250,670 (0%) 0% 50.3 348,598 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 51.07 per share. 22 Apr 2019 3,270 247,400 (0%) 0% 51.1 166,999 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 53.05 per share. 22 Apr 2019 100 246,000 (0%) 0% 53.1 5,305 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Apr 2019 15,000 144,670 - - Employee Stock Option (Right to Buy)
Patrick J. Christmas SVP, General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.10 per share. 18 Apr 2019 3,541 6,547 (0%) 0% 12.1 42,846 Common Stock
Patrick J. Christmas SVP, General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Apr 2019 1,459 9,641 - - Stock Option (Right to Buy)
Patrick J. Christmas SVP, General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Apr 2019 3,541 49,931 - - Employee Stock Option (Right to Buy)
Patrick J. Christmas SVP, General Counsel Sale of securities on an exchange or to another person at price $ 55.50 per share. 18 Apr 2019 100 3,006 (0%) 0% 55.5 5,550 Common Stock
Patrick J. Christmas SVP, General Counsel Sale of securities on an exchange or to another person at price $ 54.66 per share. 18 Apr 2019 885 3,106 (0%) 0% 54.7 48,374 Common Stock
Patrick J. Christmas SVP, General Counsel Sale of securities on an exchange or to another person at price $ 53.67 per share. 18 Apr 2019 1,115 3,991 (0%) 0% 53.7 59,842 Common Stock
Patrick J. Christmas SVP, General Counsel Sale of securities on an exchange or to another person at price $ 52.55 per share. 18 Apr 2019 2,900 5,106 (0%) 0% 52.6 152,395 Common Stock
Patrick J. Christmas SVP, General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.50 per share. 18 Apr 2019 1,459 8,006 (0%) 0% 19.5 28,451 Common Stock
Steve Pakola Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2019 95,000 95,000 - - Stock Option (Right to Buy)
Olivier Danos Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 52.23 per share. 15 Apr 2019 1,000 7,500 (0%) 0% 52.2 52,230 Common Stock
Olivier Danos Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2019 2,000 71,500 - - Stock Option (Right to Buy)
Olivier Danos Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 53.09 per share. 15 Apr 2019 1,000 6,500 (0%) 0% 53.1 53,090 Common Stock
Olivier Danos Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.35 per share. 15 Apr 2019 2,000 8,500 (0%) 0% 20.4 40,700 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 61.31 per share. 21 Mar 2019 1,700 229,215 (0%) 0% 61.3 104,227 Common Stock
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 60.64 per share. 21 Mar 2019 8,300 230,915 (0%) 0% 60.6 503,312 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 58.21 per share. 19 Mar 2019 5,870 255,130 (0%) 0% 58.2 341,693 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Mar 2019 15,000 159,670 - - Employee Stock Option (Right to Buy)
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 58.74 per share. 19 Mar 2019 9,130 246,000 (0%) 0% 58.7 536,296 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 19 Mar 2019 15,000 261,000 (0%) 0% 0.9 12,750 Common Stock
Olivier Danos Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.35 per share. 12 Mar 2019 5,000 6,500 (0%) 0% 20.4 101,750 Common Stock
Olivier Danos Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Mar 2019 5,000 73,500 - - Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Sale of securities on an exchange or to another person at price $ 60.01 per share. 05 Mar 2019 3,068 239,215 (0%) 0% 60.0 184,111 Common Stock
Curran Simpson SVP, Product Development & CTO Sale of securities on an exchange or to another person at price $ 54.05 per share. 25 Feb 2019 5,300 39,500 (0%) 0% 54.1 286,465 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2019 5,300 41,250 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.80 per share. 25 Feb 2019 5,300 44,800 (0%) 0% 35.8 189,740 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 14 Feb 2019 15,000 261,000 (0%) 0% 0.9 12,750 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 47.30 per share. 14 Feb 2019 3,522 254,066 (0%) 0% 47.3 166,591 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 45.96 per share. 14 Feb 2019 3,412 257,588 (0%) 0% 46.0 156,816 Common Stock
Kenneth T. Mills Director, President and CEO Sale of securities on an exchange or to another person at price $ 47.84 per share. 14 Feb 2019 8,066 246,000 (0%) 0% 47.8 385,877 Common Stock
Kenneth T. Mills Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2019 15,000 174,670 - - Employee Stock Option (Right to Buy)
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 07 Feb 2019 120,000 242,283 (0%) 0% 0.9 102,000 Common Stock
Vittal Vasista Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Feb 2019 120,000 84,900 - - Employee Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.50 per share. 05 Feb 2019 1,875 82,707 (0%) 0% 19.5 36,563 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.80 per share. 05 Feb 2019 8,450 47,950 (0%) 0% 35.8 302,510 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.00 per share. 05 Feb 2019 32,882 80,832 (0%) 0% 22 723,404 Common Stock
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Feb 2019 625 2,708 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Feb 2019 1,875 15,000 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Feb 2019 32,882 43,219 - - Stock Option (Right to Buy)
Curran Simpson SVP, Product Development & CTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Feb 2019 8,450 46,550 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters